08.01.06
Elan
2Q Revenues: $136.4 million (+15%)
2Q Loss: $90.5 million (loss of $142.6 million 2Q2005)
YTD Revenues: $270.7 million (+22%)
YTD Loss: $123.8 million (loss of $258.2 million YTD2005)
Comments: The net loss for the quarter was down 37%, primarily due to growth in product revenue and improved operating margins. R&D spending was down 18% to $52.6 million in the quarter. The company launched Tysabri in Germany, Ireland, UK and Sweden and re-introduced it in the U.S. in the quarter.
2Q Revenues: $136.4 million (+15%)
2Q Loss: $90.5 million (loss of $142.6 million 2Q2005)
YTD Revenues: $270.7 million (+22%)
YTD Loss: $123.8 million (loss of $258.2 million YTD2005)
Comments: The net loss for the quarter was down 37%, primarily due to growth in product revenue and improved operating margins. R&D spending was down 18% to $52.6 million in the quarter. The company launched Tysabri in Germany, Ireland, UK and Sweden and re-introduced it in the U.S. in the quarter.